true
BD Surgiphor™ Antimicrobial Irrigation System
Ready-to-use and terminally sterile.
Every bottle. Every time.
Control what you can in the OR with the next generation of surgical wound irrigation
The Operating Room is a dynamic environment where every second matters. Your choice of wound irrigation can make a difference for surgeries. The new BD Surgiphor™ Antimicrobial Irrigation System is the only pre-mixed, terminally sterile dilute povidone-iodine (PVP-I) wound irrigation system. It is ready to use, enabling you to directly deliver a dilute PVP-I lavage to mechanically loosen and remove debris and foreign materials, including microorganisms from wounds during surgery. Using the BD Surgiphor™ System, you can reduce variability in wound irrigation processes, standardize wound irrigation practice and formulation for your patients, and align with current guidelines from the CDC1, WHO2, and the American Academy of Orthopaedic Surgeons (AAOS)3 to use dilute PVP-I for surgical wound irrigation.
The BD Surgiphor™ Antimicrobial Irrigation System is a 450 mL bottle designed with multiple innovations to help you make sterility standard.
Click on each hot spot to see how it can enable you to improve control, confidence and quality assurance in the OR.
1
2
3
4
5
AAOS: American Academy of Orthopaedic Surgeons. CDC: Centers for Disease Control and Prevention. USP: United States Pharmacopeial Convention. WHO: World Health Organization.
**PVP-I is an antimicrobial preservative contained within the bottled solution. The Surgiphor solution is not indicated for use as an antimicrobial at or within the wound site. †Sterility assurance level in accordance with ISO 11137. *At initial time point of 7 days. Product should be used only within 24 hours of opening per IFU. ^Preservative solution with 0.5% PVP-I tested against Candida albicans (ATCC #10231), Pseudomonas aeruginosa (ATCC #9027), Aspergillus brasiliensis (ATCC #16404), Escherichia coli (ATCC #8739) and Staphylococcus aureus (ATCC #6538). #Shown by the in-vitro antimicrobial efficacy of the PVP-I preservative in the BD Surgiphor™ solution, as demonstrated in an in-vitro assay with measurements taken at 15 seconds, 30 seconds, 1 minute, and 5 minutes. (BD data on file)
Please consult product labels and instructions for use for indications, contraindications, hazards, warnings, and precautions.
References:
- Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection. JAMA Surg. 2017;152(8):784-791. doi: 10.1001/jamasurg.2017.0904
- World Health Organization (WHO). Global Guidelines for the Prevention of Surgical Site Infection, 2nd edition. Geneva: World Health Organization; 2018. Accessed on September 6, 2022, at https://apps.who.int/iris/rest/bitstreams/1168437/retrieve.
- American Academy of Orthopaedic Surgeons (AAOS). Intraoperative Risk Factors. In Surgical Risk Reduction Toolkit. Accessed on September 6, 2022, at https://www.aaos.org/quality/quality-programs/quality-toolkits/prevention-of-surgical-site-infection/.
- Surgiphor Gamma Sterilization Validation Test Report. Orthopor LLC; 2019.
- Association for the Advancement of Medical Instrumentation (AAMI). ANSI/AAMI ST67:2019. Sterilization of health care products—Requirements and guidance for selecting a sterility assurance level (SAL) for products labeled “sterile”. Arlington: AAMI; 2019.
- 3National Patient Safety Goals® Effective January 2023 for the Hospital Program. The Joint Commission website. http://www.jointcommission.org/-/media/tjc/documents/standards/national-patient-safety-goals/2023/npsg_chapter_hap_jan2023.pdf. Published January 2023. Accessed January 26, 2023.
- Surgiphor System Mechanical Action Report. Orthopor LLC; 2019.
- Surgiphor Solution Preservative Effectiveness Report. Orthopor LLC; 2019.
- Antimicrobial Efficacy Evaluation of 0.5% PVP-I and Irrisept® by In Vitro Time-Kill Assay. Internal report. Sidhu, P; 2021.
- Goswami K, Austin MS. Intraoperative povidone-iodine irrigation for infection prevention. Arthroplast Today. 2019;5(3):306-308. Published 2019 May 22. doi:10.1016/j.artd.2019.04.004
- Antimicrobial Efficacy Evaluation of 0 .5 % PVP-I by In Vitro Time- Kill Assay. Internal report. Sidhu, P; 2020.
true